Neurogenetics

, Volume 7, Issue 3, pp 133–138 | Cite as

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan

  • Alessio Di Fonzo
  • Yah-Huei Wu-Chou
  • Chin-Song Lu
  • Marina van Doeselaar
  • Erik J. Simons
  • Christan F. Rohé
  • Hsiu-Chen Chang
  • Rou-Shayn Chen
  • Yi-Hsin Weng
  • Nicola Vanacore
  • Guido J. Breedveld
  • Ben A. Oostra
  • Vincenzo Bonifati
Original Article

Abstract

Mutations in the LRRK2 gene are a cause of autosomal dominant Parkinson’s disease (PD). Whether LRRK2 variants influence susceptibility to the commoner, sporadic forms of PD remains largely unknown. Data are particularly limited concerning the Asian population. In search for novel, biologically relevant variants, we sequenced the LRRK2 coding region in Taiwanese patients with PD. Four newly identified variants and another variant recently found in a Taiwanese PD family were tested for association with the disease in a sample of 608 PD cases and 373 ethnically matched controls. Heterozygosity for the Gly2385Arg variant was significantly more frequent among PD patients than controls (nominal p value=0.004, corrected for multiple comparisons=0.012, gender- and age-adjusted odds ratio=2.24, 95% C.I.: 1.29–3.88); this variant was uniformly distributed across genders and age strata. Two novel variants, Met1869Val and Glu1874Stop, were found in one PD case each; their pathogenic role remains, therefore, uncertain. The remaining two novel variants (Ala419Val and Pro755Leu) were present with similar frequency in cases and controls, and were therefore, interpreted as disease-unrelated polymorphisms. Our findings suggest that the LRRK2 Gly2385Arg is the first identified, functionally relevant variant, which acts as common risk factor for sporadic PD in the population of Chinese ethnicity.

Keywords

Parkinson’s disease LRRK2 Mutation Polymorphism Risk factor Taiwan 

References

  1. 1.
    Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, de Munain AL, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Carrera IM, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 44:595–600PubMedCrossRefGoogle Scholar
  2. 2.
    Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44:601–607PubMedCrossRefGoogle Scholar
  3. 3.
    Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson’s disease. Lancet 365:412–415PubMedGoogle Scholar
  4. 4.
    Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet 365:415–416PubMedGoogle Scholar
  5. 5.
    Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M (2005) Identification of a novel LRRK2 mutation linked to autosomal dominant Parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76:672–680PubMedCrossRefGoogle Scholar
  6. 6.
    Lesage S, Leutenegger A-L, Ibanez P, Janin S, Lohmann E, Durr A, Brice A (2005) LRRK2 haplotype analyses in European and North African families with Parkinson’s disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 77:330–332PubMedCrossRefGoogle Scholar
  7. 7.
    Goldwurm S, Di Fonzo A, Simons EJ, Rohe CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V (2005) The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor. J Med Genet 42:e65PubMedCrossRefGoogle Scholar
  8. 8.
    Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A (2006) LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs. N Engl J Med 354:422–423PubMedCrossRefGoogle Scholar
  9. 9.
    Ozelius LJ, Senthil G, Saunders-Pullman R, Ohmann E, Deligtisch A, Tagliati M, Hunt AL, Klein C, Henick B, Hailpern SM, Lipton RB, Soto-Valencia J, Risch N, Bressman SB (2006) LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N Engl J Med 354:424–425PubMedCrossRefGoogle Scholar
  10. 10.
    Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F (2005) An LRRK2 mutation as a cause for the Parkinsonism in the original PARK8 family. Ann Neurol 57:918–921PubMedCrossRefGoogle Scholar
  11. 11.
    Tan EK, Shen H, Tan LC, Farrer M, Yew K, Chua E, Jamora RD, Puvan K, Puong KY, Zhao Y, Pavanni R, Wong MC, Yih Y, Skipper L, Liu JJ (2005) The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson’s disease patients. Neurosci Lett 384:327–329PubMedCrossRefGoogle Scholar
  12. 12.
    Lu CS, Simons EJ, Wu-Chou YH, Di Fonzo A, Chang HC, Chen RS, Weng YH, Rohe CF, Breedveld GJ, Hattori N, Gasser T, Oostra BA, Bonifati V (2005) The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson’s disease. Parkinsonism Relat Disord 11:521–522PubMedCrossRefGoogle Scholar
  13. 13.
    Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS, Lahoz C, Wszolek ZK, Farrer MJ (2005) LRRK2 pathogenic substitutions in Parkinson’s disease. Neurogenetics 6:171–177PubMedCrossRefGoogle Scholar
  14. 14.
    Biskup S, Mueller JC, Sharma M, Lichtner P, Zimprich A, Berg D, Wullner U, Illig T, Meitinger T, Gasser T (2005) Common variants of LRRK2 are not associated with sporadic Parkinson’s disease. Ann Neurol 58:905–908PubMedCrossRefGoogle Scholar
  15. 15.
    Skipper L, Li Y, Bonnard C, Pavanni R, Yih Y, Chua E, Sung WK, Tan L, Wong MC, Tan EK, Liu J (2005) Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson’s disease. Hum Mol Genet 14:3549–3556PubMedCrossRefGoogle Scholar
  16. 16.
    Paisan-Ruiz C, Lang AE, Kawarai T, Sato C, Salehi-Rad S, Fisman GK, Al-Khairallah T, St George-Hyslop P, Singleton A, Rogaeva E (2005) LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 65:696–700PubMedCrossRefGoogle Scholar
  17. 17.
    Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRefGoogle Scholar
  18. 18.
    Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohe CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Meco G, Leitner P, Uitti RJ, Wszolek ZK, Gasser T, Simons EJ, Breedveld GJ, Goldwurm S, Pezzoli G, Sampaio C, Barbosa E, Martignoni E, Oostra BA, Bonifati V (2006) Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson’s disease. Eur J Hum Genet 14:322–331PubMedCrossRefGoogle Scholar
  19. 19.
    Newton-Cheh C, Hirschhorn JN (2005) Genetic association studies of complex traits: design and analysis issues. Mutat Res 573:54–69PubMedGoogle Scholar
  20. 20.
    Farrer M, Stone J, Mata IF, Lincoln S, Kachergus J, Hulihan M, Strain KJ, Maraganore DM (2005) LRRK2 mutations in Parkinson disease. Neurology 65:738–740PubMedCrossRefGoogle Scholar
  21. 21.
    West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102:16842–16847PubMedCrossRefGoogle Scholar
  22. 22.
    Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O’Neill E, Meitinger T, Kolch W, Prokisch H, Ueffing M (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 15:223–232PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Alessio Di Fonzo
    • 1
    • 5
  • Yah-Huei Wu-Chou
    • 2
    • 4
  • Chin-Song Lu
    • 2
    • 3
  • Marina van Doeselaar
    • 1
  • Erik J. Simons
    • 1
  • Christan F. Rohé
    • 1
  • Hsiu-Chen Chang
    • 2
  • Rou-Shayn Chen
    • 2
    • 3
  • Yi-Hsin Weng
    • 2
    • 3
  • Nicola Vanacore
    • 6
  • Guido J. Breedveld
    • 1
  • Ben A. Oostra
    • 1
  • Vincenzo Bonifati
    • 1
  1. 1.Department of Clinical GeneticsErasmus MC RotterdamRotterdamThe Netherlands
  2. 2.Neuroscience Research CenterChang Gung Memorial Hospital, Chang Gung University College of MedicineTaipeiRepublic of China
  3. 3.Department of NeurologyChang Gung Memorial Hospital, Chang Gung University College of MedicineTaipeiRepublic of China
  4. 4.Human Molecular Genetics LaboratoryChang Gung Memorial Hospital, Chang Gung University College of MedicineTaipeiRepublic of China
  5. 5.Centro Dino Ferrari, Department of Neurological SciencesUniversity of Milan, and Foundation “Ospedale Maggiore PoliclinicoMilanItaly
  6. 6.National Centre of EpidemiologyNational Institute for HealthRomeItaly

Personalised recommendations